Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis
Authors:
- 1 December 2017
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 29 (12) , 1416-1423
Abstract
Background/aim: Sarcopenia is recognized as a condition related to quality of life and prognosis in patients with chronic liver disease, although no useful strategy for improving muscle volume and strength has been established. Here, we evaluated the efficacy of supplementation with branched-chain amino acid (BCAA) administration and walking exercise. Patients and methods: From December 2015 to July 2016, 33 Japanese outpatients with liver cirrhosis were enrolled (median: 67 years, HCV : HBV : alcohol : others=26 : 2 : 2 : 3, male : female=13 : 20, Child-Pugh A : B=30 : 3). None had a history of BCAA supplementation. After calculating the average number of daily steps using a pedometer for a 2–3-week period, BCAA supplementation (protein 13.5 g, 210 kcal/day) as a late evening snack and walking exercise (additional 2000 steps/day prescribed) were started. Body composition including muscle volume was analyzed using a bioelectrical impedance analysis method, and serological data and muscle strength (leg, handgrip) were evaluated at enrollment, and then 1, 2, and 3 months after starting the protocol. Results: The median average number of daily steps was 3791 (interquartile range: 2238–5484). The average period of BCAA supplementation was 2.7±0.7 months. During the period from enrollment to 3 months after starting the protocol, HbA1c and NH3 were not significantly changed, whereas the BCAA/tyrosine ratio improved (4.3±1.35 to 5.24±2.04, P=0.001). In addition, the ratios for average daily steps (1.595, P=0.02) as well as muscle volume, leg strength, and handgrip strength (1.013, 1.110, and 1.056, respectively; all P<0.01) were increased at 3 months. Conclusion: BCAA supplementation and walking exercise were found to be effective and easily implemented for improving muscle volume and strength in liver cirrhosis patients.Keywords
This publication has 19 references indexed in Scilit:
- Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteriaHepatology Research, 2016
- Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenibHepatology Research, 2016
- Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver diseaseEuropean Journal of Gastroenterology & Hepatology, 2016
- Effects of in‐hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver diseaseHepatology Research, 2016
- Impact of muscle wasting on survival in patients with liver cirrhosisWorld Journal of Gastroenterology, 2015
- Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with CirrhosisDigestive Diseases and Sciences, 2014
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Summary commentsThe American Journal of Clinical Nutrition, 1989
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973